Similarly, the level of IL-4 in the serum of the AD group mice was elevated compared with the control group, and after treatment with 10, 15, 20 and 30 mg/kg AZF, the expression levels of serum IL-4 were reduced (Figure 3B). This evidence concerns the gene IL4 and Alzheimer disease.